Company intelligence / Profile preview

Ribbon Bio

Vienna, Vienna, Austria

Ownership: Private
Development stage: Commercial

Overview

Ribbon Bio is an active Vienna-based synthetic biology company specializing in high-throughput, automated synthesis of long and complex synthetic DNA molecules. Their proprietary InfiniSynth™ platform uses algorithm-driven design and multiplexed enzymatic assembly to deliver highly accurate (>1 in 90,000 accuracy), pure custom DNA constructs up to at least 20 kilobase pairs. They serve biopharma, gene therapy developers, agricultural biotech firms, and academic researchers by providing tailored solutions that enable advanced R&D across multiple life science sectors.

Modalities: Synthetic DNA
Industry: Non-Drug Biotech

Partnerships

No major pharmaceutical or biotech partnerships are specifically named in public sources as of June 2025. However, the company collaborates with various industry players and views some competitors as potential collaborators.

Beyond the preview

Go deeper on Ribbon Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribbon Bio.

Explore the full profile